Navigation Links
Patients -- Not ERs and Big Pharma -- Need Protection
Date:4/14/2011

RALEIGH, N.C., April 14, 2011 /PRNewswire/ -- Immunity shields for ERs that commit malpractice and pharmaceutical companies that sell bad drugs are unnecessary and dangerous.  Yet both are centerpieces of legislation under consideration by the House Special Committee on Tort Reform, which meets again on Thursday at 11am.  

Today, the North Carolina Coalition for Patient Safety (NC-CPS) released a new report -- based on NC court files -- showing that there were only five verdicts in NC against providers of ER care from 1999 through 2010, and only one since 2004. The highest verdict against a doctor or hospital based on substandard ER care was $650,000.

There are 4,000,000 ER visits per year in North Carolina. That means there has been about one verdict per 8,000,000 ER visits since 1999.

On Thursday, the House Select Committee on Tort Reform will vote on Senate Bill 33.  The bill includes a provision making negligence in the ER legal: an ER doctor could only be found liable if he intentionally harmed the patient.

Lobbyists for the North Carolina Medical Society have argued that providers of ER care need special legislative protection from liability.  The facts, however, do not support their argument.

Laurie Sanders, Executive Director of NC-CPS commented on the new report: "Under the current legal standard, providers of ER care have a tiny risk of being found liable for malpractice.  At the same time, 4,000 patients die and 5,700 are permanently injured in North Carolina hospitals every year because of preventable medical mistakes.  We need to give more protection to patients, not to the negligent hospitals and doctors who harm them."

Letter from Grieving Father

The committee will also vote Thursday on granting immunity to negligent drug manufacturers.  In a letter to Committee Chair Johnathan Ryhne, Andy Ayers of Eden, NC describes the death of his wife Tamara at age 22 because of a drug called Parlodel.  Tamara died just eight days after giving birth.

"My son never had the chance to be rocked to sleep or kissed goodnight by his mother," Ayers writes. "Please do not grant immunity to drug companies for their wrongdoing to North Carolinians."

Under the bill, drug companies could not be sued by those harmed by defective and dangerous drugs unless the company obtained FDA approval by fraud or bribery.  Even if the product is later found to be harmful or deadly, the drug manufacturer -- so long as it had FDA approval -- cannot be held liable.  Only one other state, Michigan, has passed a similarly extreme law, and it was the subject of a repeal movement this year.

For more information, please contact Todd@ncaj.com. Follow our news on Facebook http://www.facebook.com/pages/NC-Law-and-Politics/191212774245068 and on our website www.LetJuriesDecide.com.


'/>"/>
SOURCE NC Advocates for Justice
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
2. Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients
3. Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea
4. Texas Independent Drugstore Lobby (Continues) Putting Profits Ahead of Patients
5. Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes
6. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
9. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
10. New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation
11. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... May 4, 2016 ... the  "Global Multiple Myeloma Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Myeloma epidemiology, Multiple Myeloma market valuations and ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/4/2016)... 2016 Research and ... Acute lymphocytic Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and The ZAC ... a new partnership to reach nearly 1 million children with important water safety messages ... is the leading cause of accidental death in children one to 6 years of ...
(Date:5/5/2016)... ... 05, 2016 , ... The 2016 Nike Soccer Camp will be directed by ... coaching staff. Together they bring their winning Vandals coaching philosophy to young athletes. Programs ... 5-13, and high school players. Session dates are as follows: , Youth Day Camp ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Collection Bureau, Inc. (UCB) announces ... more than 15 years of experience within the healthcare revenue cycle industry. With a ... the Director of Patient Financial Services at Spectrum Health. While at Spectrum Health, Clark ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... honored finalists and winners Tuesday evening, May 3, at the 2016 ISE® Central ... , Scott Pettigrew, Vice President and Chief Security Officer of HMS, was selected ...
(Date:5/5/2016)... ... May 05, 2016 , ... ACLS Certification Institute, a ... new referral program, giving participants incentive for spreading the word about the Institute’s ... know many professionals share resources with their friends and colleagues,” said Vonda Andrews, ...
Breaking Medicine News(10 mins):